Avelos Therapeutics

Developer of biomarker-driven anti-cancer targeted therapies

placeGangseo, Yeongnam, South Korea calendar_todayFounded 2021 groups15 employees language avelostx.com

Investor mix

13 investors on record; lead investors include QUAD, Time Polio Asset Management, Mirae Asset Capital Markets, Mirae Asset.

Investor typeCountShare
Venture capital538%
Private equity18%
Bank & private debt323%
Other / undisclosed431%
Coming soon